A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...

Medicare is big business, recently providing healthcare coverage to 68 million people. It changes a little or a lot every ...

Millions of Part D patients who rely on price-controlled drugs will see their out-of-pocket medication costs increase.

The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...

The Inflation Reduction Act of 2022 has triggered a raft of changes to Medicare Part D plans and Medicare Advantage plans that affect prescription drug coverage in 2025. Here’s what to know.

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

Despite online claims, President Donald Trump’s executive orders did not include removing Medicare’s $35 monthly ...

The talks around drugs including Novo Nordisk’s Wegovy, GSK’s Trelegy Ellipta, and Pfizer’s Xtandi will set Medicare prices ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...